INVO Bioscience, Inc. entered into a Merchant Cash Advance Agreement, receiving $251,750 for future sales, agreeing to pay $9,606 weekly until repaid, and must secure $1,000,000 in equity by November 30, 2024, to avoid increased interest rates.